9780309120883 - breakthrough business models: drug development for rare and neglected diseases and individualized therapies: workshop summary (clinical trial data sharing) de institute of medicine; board on health sciences policy; forum on drug discovery, development, and translation; giffin, robert; robinson, sally; wizemann, theresa (11 resultados)
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
Wizemann, Theresa M.; Robinson, Sally; Giffin, Robert; Institute of Medicine (U. S.) (COR)
- Tapa blanda
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Como Nuevo
EUR 54,87
Envío por EUR 2,30Se envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponibles
Condición: As New. Unread book in perfect condition.
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
Wizemann, Theresa M.; Robinson, Sally; Giffin, Robert; Institute of Medicine (U. S.) (COR)
- Tapa blanda
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 59,45
Envío por EUR 2,30Se envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponibles
Condición: New.
- Tapa blanda
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 61,83
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponibles
Paperback. Condición: new. Paperback. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare…and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
Wizeman, Theresa; Robinson, Sally; Giffin, Robert; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute
- Tapa blanda
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandaKennys Bookshop and Art Galleries Ltd.
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 62,87
Envío por EUR 10,50Se envía de Irlanda a Estados Unidos de AmericaCantidad disponible: 10 disponibles
Condición: New. Num Pages: 150 pages. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 10. Weight in Grams: 249. . 2009. New. paperback. . . . .
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
Wizemann, Theresa M.; Robinson, Sally; Giffin, Robert; Institute of Medicine (U. S.) (COR)
- Tapa blanda
Librería: GreatBookPricesUK, Woodford Green, Reino UnidoGreatBookPricesUK
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Como Nuevo
EUR 60,65
Envío por EUR 17,28Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Condición: As New. Unread book in perfect condition.
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies
Wizemann, Theresa M./ Robinson, Sally/ Giffin, Robert/ Institute of Medicine (U. S.)
- Tapa blanda
Librería: Revaluation Books, Exeter, , Reino UnidoRevaluation Books
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 69,39
Envío por EUR 11,52Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Paperback. Condición: Brand New. 150 pages. 8.80x6.00x0.40 inches. In Stock.
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
Wizemann, Theresa M.; Robinson, Sally; Giffin, Robert; Institute of Medicine (U. S.) (COR)
- Tapa blanda
Librería: GreatBookPricesUK, Woodford Green, Reino UnidoGreatBookPricesUK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 69,78
Envío por EUR 17,28Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Condición: New.
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
Wizeman, Theresa; Robinson, Sally; Giffin, Robert; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute
- Tapa blanda
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de AmericaKennys Bookstore
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 79,56
Envío por EUR 9,16Se envía dentro de Estados Unidos de AmericaCantidad disponible: 10 disponibles
Condición: New. Num Pages: 150 pages. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 10. Weight in Grams: 249. . 2009. New. paperback. . . . . Books ship from the US and Ireland.
- Tapa blanda
Librería: THE SAINT BOOKSTORE, Southport, , Reino UnidoTHE SAINT BOOKSTORE
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 75,79
Envío por EUR 15,60Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Paperback / softback. Condición: New. New copy - Usually dispatched within 4 working days.
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
Institute of Medicine|Board on Health Sciences Policy|Forum on Drug Discovery Development and
- Tapa blanda
Librería: moluna, Greven, , Alemaniamoluna
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 53,75
Envío por EUR 48,99Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Condición: New.
- Tapa blanda
Librería: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 96,30
Envío por EUR 32,28Se envía de Australia a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Paperback. Condición: new. Paperback. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare…and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
